PARADIGHM (Physicians Advancing Knowledge of Chronic Hypoparathyroidism): A Registry Study for Patients with Hypoparathyroidism. SHI-PTH-2019-01
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: TAKEDA PHARMACEUTICALS INTERNATIONAL AG
- Execution start: 23/11/2020
- End of execution: 30/12/2034
- PI: MANUEL EDUARDO MUÑOZ TORRES